drug

nanvuranlat

Phase 3updated 3mo ago

by J-Pharma Co Ltd

Phase 3

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying nanvuranlat

phase3A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancerrecruitingn=480

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 32m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

nanvuranlat

Phase 3updated 3mo ago

by J-Pharma Co Ltd

Phase 3

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying nanvuranlat

phase3A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancerrecruitingn=480

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 32m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

nanvuranlat

all catalysts(0)

Trials studying nanvuranlat

News(0)

Report a data issue

comments(0)

nanvuranlat

all catalysts(0)

Trials studying nanvuranlat

News(0)

Report a data issue

comments(0)